HIGHLIGHTS
- who: Yu-Chao Lin and colleagues from the Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical School of Medicine, China Medical University, Taichung, Taiwan have published the research: In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein, in the Journal: (JOURNAL) of 28/Nov/2021
- what: The authors aimed to fine tune the binding affinity of the RBD-1C aptamer through the proposed approaches. The models of DNA aptamers were used in the subsequent molecular simulations. In this study, all computations were carried out on the HP 14 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.